The relationship between schizoaffective, schizophrenic and mood disorders in patients admitted at Mathari Psychiatric Hospital, Nairobi, Kenya.

D M Ndetei, L Khasakhala, L Meneghini, J L Aillon
{"title":"The relationship between schizoaffective, schizophrenic and mood disorders in patients admitted at Mathari Psychiatric Hospital, Nairobi, Kenya.","authors":"D M Ndetei, L Khasakhala, L Meneghini, J L Aillon","doi":"10.4314/ajpsy.v16i2.14","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The prevalence of schizoaffective disorder (SAD) and the relationship between schizophrenia (SCZ), SAD and mood disorders (MD) in non-Western countries is unknown. To determine the prevalence of SAD and the relationship between SCZ, SAD and MD in relation to socio-demographic, clinical and therapeutic variables in 691 patients admitted at Mathari Psychiatric Hospital, Kenya.</p><p><strong>Method: </strong>A cross-sectional comparative study using both clinician and SCID-1 for DSM-IV diagnoses.</p><p><strong>Results: </strong>Approximately twenty three percent (n=160) met DSM-IV criteria for SAD using SCID-1. There were significant differences between SCZ, SAD and MD regarding: affective and core symptoms of schizophrenia (with the exception of core symptoms of schizophrenia between SCZ and SAD); presence of past trauma; a past suicide attempt; and comorbidity with alcohol and drug abuse disorders. SAD and MD patients took significantly more mood stabilizers than SCZ patients. There were no significant differences between the three groups regarding socio-demographic variables, brief psychiatric rating scale scores, cognitive performance, anxiety and depressive symptoms, presence of obsessions, and usage of both antipsychotics and antidepressants.</p><p><strong>Conclusion: </strong>There is no distinct demarcation between the three disorders. This lends support to recent evidence suggesting that SAD might constitute a heterogeneous group composed of both SCZ and MD patients or a middle point of a continuum between SCZ and MD.</p>","PeriodicalId":55549,"journal":{"name":"African Journal of Psychiatry","volume":"16 2","pages":"110-7"},"PeriodicalIF":0.0000,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Journal of Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/ajpsy.v16i2.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The prevalence of schizoaffective disorder (SAD) and the relationship between schizophrenia (SCZ), SAD and mood disorders (MD) in non-Western countries is unknown. To determine the prevalence of SAD and the relationship between SCZ, SAD and MD in relation to socio-demographic, clinical and therapeutic variables in 691 patients admitted at Mathari Psychiatric Hospital, Kenya.

Method: A cross-sectional comparative study using both clinician and SCID-1 for DSM-IV diagnoses.

Results: Approximately twenty three percent (n=160) met DSM-IV criteria for SAD using SCID-1. There were significant differences between SCZ, SAD and MD regarding: affective and core symptoms of schizophrenia (with the exception of core symptoms of schizophrenia between SCZ and SAD); presence of past trauma; a past suicide attempt; and comorbidity with alcohol and drug abuse disorders. SAD and MD patients took significantly more mood stabilizers than SCZ patients. There were no significant differences between the three groups regarding socio-demographic variables, brief psychiatric rating scale scores, cognitive performance, anxiety and depressive symptoms, presence of obsessions, and usage of both antipsychotics and antidepressants.

Conclusion: There is no distinct demarcation between the three disorders. This lends support to recent evidence suggesting that SAD might constitute a heterogeneous group composed of both SCZ and MD patients or a middle point of a continuum between SCZ and MD.

肯尼亚内罗毕Mathari精神病院住院患者的精神分裂情感性、精神分裂症和情绪障碍之间的关系。
目的:非西方国家分裂情感性障碍(SAD)患病率及精神分裂症(SCZ)、SAD与心境障碍(MD)的关系尚不清楚。目的确定肯尼亚Mathari精神病院691例患者的SAD患病率,以及SCZ、SAD和MD与社会人口统计学、临床和治疗变量之间的关系。方法:采用临床医师和SCID-1对DSM-IV诊断进行横断面比较研究。结果:大约23% (n=160)的患者使用SCID-1符合DSM-IV的SAD标准。SCZ、SAD和MD在精神分裂症情感症状和核心症状方面存在显著差异(SCZ与SAD之间精神分裂症核心症状除外);过去创伤的存在;过去的自杀企图;以及酒精和药物滥用障碍的共病。SAD和MD患者服用的情绪稳定剂明显多于SCZ患者。在社会人口学变量、简短精神病学评定量表得分、认知表现、焦虑和抑郁症状、强迫症的存在以及抗精神病药物和抗抑郁药物的使用方面,三组之间没有显著差异。结论:三种疾病之间没有明显的界限。这支持了最近的证据,表明SAD可能是由SCZ和MD患者组成的异质群体,或者是SCZ和MD之间连续体的中间点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
>12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书